financetom
Business
financetom
/
Business
/
Alto Ingredients to Idle Idaho Facility on Dec. 31
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alto Ingredients to Idle Idaho Facility on Dec. 31
Nov 29, 2024 6:19 AM

08:58 AM EST, 11/29/2024 (MT Newswires) -- Alto Ingredients ( ALTO ) said Friday it will temporarily idle its Magic Valley, Idaho facility on Dec. 31 amid expectations for "very low to negative crush margins" in Q1.

The producer of specialty alcohols said it will continue to offer terminal services at the plant. It also said it plans to resume full operations when economic conditions improve "on a more sustainable basis."

Alto said it expects its decision to idle the facility to "have a positive impact" on its financial results.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ecuador reopens mining concession registry after seven years
Ecuador reopens mining concession registry after seven years
Jun 16, 2025
QUITO (Reuters) -Ecuador's mining ministry announced on Monday the launch of a new registry of concessions for the first time in seven years in an effort to attract more mining projects to the South American country and curb illegal operations. The prior registry was shut down in 2018 over concerns of irregularities in the concession system, and no new concessions...
Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports
Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports
Jun 16, 2025
June 16 (Reuters) - Eli Lilly ( LLY ) is in advanced talks to acquire gene editing startup Verve Therapeutics ( VERV ) for up to $1.3 billion, aiming to strengthen its pipeline of experimental medicines, the Financial Times reported on Monday. The drug maker's acquisition bid includes a payment of almost $1 billion upfront for Verve, and a further...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports
Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports
Jun 16, 2025
(Reuters) -Eli Lilly ( LLY ) is in advanced talks to acquire gene editing startup Verve Therapeutics ( VERV ) for up to $1.3 billion, aiming to strengthen its pipeline of experimental medicines, the Financial Times reported on Monday. The drug maker's acquisition bid includes a payment of almost $1 billion upfront for Verve, and a further $300 million based...
Copyright 2023-2026 - www.financetom.com All Rights Reserved